Lsv Asset Management Bristol Myers Squibb CO Transaction History

Lsv Asset Management

$46.7 Billion
Q3 2024

A detailed history of Lsv Asset Management transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Lsv Asset Management holds 8,545,291 shares of BMY stock, worth $494 Million. This represents 0.95% of its overall portfolio holdings.

Number of Shares

8,545,291

Previous 8,280,905 3.19%

Holding current value

$494 Million

Previous $344 Million 28.56%

% of portfolio

0.95%

Previous 0.75%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$39.66 - $51.75 $10.5 Million - $13.7 Million	264,386 Added 3.19%	8,545,291 $442 Million
Q2 2024 Aug 06, 2024	SELL	$40.25 - $52.99 $10.1 Million - $13.3 Million	-251,336 Reduced 2.95%	8,280,905 $344 Million
Q1 2024 May 06, 2024	SELL	$47.98 - $54.4 $9.75 Million - $11.1 Million	-203,222 Reduced 2.33%	8,532,241 $463 Million
Q4 2023 Feb 06, 2024	SELL	$48.48 - $57.85 $12.7 Million - $15.1 Million	-261,300 Reduced 2.9%	8,735,463 $448 Million
Q3 2023 Nov 03, 2023	SELL	$57.89 - $64.73 $23.3 Million - $26 Million	-401,892 Reduced 4.28%	8,996,763 $522 Million
Q2 2023 Aug 02, 2023	SELL	$63.71 - $70.74 $177,177 - $196,727	-2,781 Reduced 0.03%	9,398,655 $601 Million
Q1 2023 May 02, 2023	SELL	$65.71 - $74.53 $2.85 Million - $3.23 Million	-43,401 Reduced 0.46%	9,401,436 $652 Million
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $32.5 Million - $38.5 Million	-474,618 Reduced 4.78%	9,444,837 $680 Million
Q3 2022 Nov 07, 2022	SELL	$0.13 - $76.84 $7,383 - $4.36 Million	-56,798 Reduced 0.57%	9,919,455 $705 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $18.9 Million - $20.9 Million	-260,793 Reduced 2.55%	9,976,253 $768 Million
Q1 2022 May 12, 2022	BUY	$61.48 - $73.72 $4.68 Million - $5.62 Million	76,197 Added 0.75%	10,237,046 $748 Million
Q4 2021 Jan 28, 2022	SELL	$53.63 - $62.52 $16.8 Million - $19.5 Million	-312,640 Reduced 2.99%	10,160,849 $634 Million
Q3 2021 Nov 04, 2021	SELL	$59.17 - $69.31 $10.1 Million - $11.9 Million	-171,154 Reduced 1.61%	10,473,489 $620 Million
Q2 2021 Aug 04, 2021	BUY	$61.91 - $67.42 $5.53 Million - $6.02 Million	89,320 Added 0.85%	10,644,643 $711 Million
Q1 2021 Apr 30, 2021	SELL	$59.34 - $66.74 $32.3 Million - $36.3 Million	-544,265 Reduced 4.9%	10,555,323 $666 Million
Q4 2020 Feb 08, 2021	SELL	$57.74 - $65.43 $27.6 Million - $31.2 Million	-477,214 Reduced 4.12%	11,099,588 $689 Million
Q3 2020 Oct 23, 2020	BUY	$57.43 - $63.64 $14.5 Million - $16.1 Million	253,311 Added 2.24%	11,576,802 $698 Million
Q2 2020 Aug 05, 2020	BUY	$54.82 - $64.09 $85.2 Million - $99.6 Million	1,553,690 Added 15.9%	11,323,491 $666 Million
Q1 2020 May 07, 2020	BUY	$46.4 - $67.43 $1.43 Million - $2.07 Million	30,757 Added 0.32%	9,769,801 $545 Million
Q4 2019 Feb 10, 2020	BUY	$49.21 - $64.19 $291 Million - $379 Million	5,908,344 Added 154.24%	9,739,044 $625 Million
Q3 2019 Nov 07, 2019	BUY	$42.77 - $50.71 $157 Million - $186 Million	3,662,100 Added 2172.06%	3,830,700 $194 Million
Q4 2018 Feb 05, 2019	BUY	$48.76 - $63.23 $6.41 Million - $8.31 Million	131,469 Added 354.07%	168,600 $8.76 Million
Q3 2018 Nov 06, 2018	BUY	$55.19 - $62.25 $1.56 Million - $1.76 Million	28,231 Added 317.2%	37,131 $2.31 Million
Q2 2018 Aug 08, 2018	BUY	$50.53 - $62.98 $449,717 - $560,522	8,900 New	8,900 $492,000
Q4 2017 Feb 01, 2018	SELL	$59.94 - $65.35 $479,520 - $522,799	-8,000 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $441,840 - $509,920	8,000	8,000 $509,000

Others Institutions Holding BMY

# of Institutions

2,536

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $123B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lsv Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Lsv Asset Management with notifications on news.

Account

Lsv Asset Management Bristol Myers Squibb CO Transaction History